ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

PSTX Poseida Therapeutics Inc

2.77
0.00 (0.00%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Poseida Therapeutics Inc PSTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 2.77 09:00:00
始値 安値 高値 終値 前日終値
2.77
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0210:30PRNUSAstellas and Poseida Therapeutics Enter Into Research..
2024/5/0204:25APSBiotech Soars on Research Collaboration And License..
2024/5/0122:00PRNUSAstellas and Poseida Therapeutics Enter Into Research..
2024/4/1821:00PRNUSPoseida Therapeutics Announces Strong Lineup of..
2024/4/1722:00PRNUSPoseida Therapeutics Hosts Gene Therapy R&D Day Highlighting..
2024/4/0901:00PRNUSPoseida Therapeutics Presents New Phase 1 Data at AACR 2024..
2024/4/0205:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
2024/3/2605:05PRNUSPoseida Therapeutics Appoints Syed Rizvi, M.D., as Chief..
2024/3/2005:05PRNUSPoseida Therapeutics to Present at H.C. Wainwright 2nd..
2024/3/1405:05PRNUSPoseida Therapeutics Announces FDA Orphan Drug Designation..
2024/3/0806:07PRNUSPoseida Therapeutics Provides Updates and Financial Results..
2024/3/0806:05EDGAR2Form 8-K - Current report
2024/3/0507:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0507:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
2024/2/0906:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/0506:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:01EDGAR2Form 8-K - Current report
2024/1/0422:00PRNUSPoseida Therapeutics Highlights Recent Progress, Strategic..
2023/12/1200:31DJNPoseida Therapeutics Shares Climb on Positive Data for Blood..
2023/12/1120:06EDGAR2Form 8-K - Current report
2023/12/1102:00PRNUSPoseida Therapeutics Presents Positive Early Results from..
2023/11/1006:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:05EDGAR2Form 8-K - Current report
2023/11/1006:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
2023/11/0722:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
2023/11/0222:01PRNUSPoseida Therapeutics to Present at the 65th ASH Annual..
2023/10/1005:30PRNUSPoseida Therapeutics Announces Leadership Transition
2023/9/0521:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
2023/8/1505:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/8/1205:48EDGAR2Form D - Notice of Exempt Offering of Securities
2023/8/0905:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:06EDGAR2Form 8-K - Current report
2023/8/0905:05PRNUSPoseida Therapeutics Provides Financial Results for the..
2023/8/0723:41DJNPoseida Therapeutics Shares Leap on Astellas Investments
2023/8/0722:58DJNPoseida Therapeutics in $50 Million Investment Deal With..
2023/8/0722:01EDGAR2Form 8-K - Current report
2023/8/0722:01PRNUSPoseida Therapeutics Announces Strategic Investment by..
2023/8/0722:00PRNUSAstellas and Poseida Therapeutics Announce Strategic..
2023/7/0521:00PRNUSPoseida Therapeutics Announces FDA Clearance of..
2023/6/2621:00PRNUSPoseida Therapeutics to Join Russell 3000® and Russell 2000®..
2023/6/0121:00PRNUSPoseida Therapeutics Announces Virtual 2023 Annual Meeting..
2023/5/2321:00PRNUSPoseida Therapeutics to Present at Stifel 2023 Tailoring..
2023/5/2221:00PRNUSPoseida Therapeutics to Present at 31st Congress of the..
2023/5/1821:00PRNUSPoseida Therapeutics Presents Encouraging Preclinical Data..
2023/5/1005:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..

最近閲覧した銘柄

Delayed Upgrade Clock